Literature DB >> 18765150

Intensity-modulated radiation therapy for gastrointestinal tumors.

Jeffrey J Meyer1, Brian G Czito, Christopher G Willett.   

Abstract

Radiation plays an important role in the multimodal management of tumors of the gastrointestinal (GI) system. Intensity-modulated radiation therapy (IMRT) is a technological development that was introduced to limit the acute and late toxicities commonly associated with conventional radiation therapy. Numerous preclinical dosimetric comparisons of conventional and intensity-modulated radiation plans for treating various GI tumors have been reported. In general, these studies have shown that IMRT can spare organs at risk in the high-dose region while maintaining adequate target coverage. Clinical reports on the efficacy and tolerability of IMRT are emerging. This review provides a description of the differences between conventional irradiation and IMRT and discusses the preclinical and early clinical investigations of the role of IMRT in the treatment of GI tumors. The ultimate role of IMRT in GI tumor management will be determined through further clinical study.

Entities:  

Mesh:

Year:  2008        PMID: 18765150     DOI: 10.1007/s11912-008-0032-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  45 in total

Review 1.  Partial volume tolerance of the liver to radiation.

Authors:  Laura A Dawson; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2005-10       Impact factor: 5.934

2.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients.

Authors:  Z X Zhang; X Z Gu; W B Yin; G J Huang; D W Zhang; R G Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

3.  Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.

Authors:  Aaron C Spalding; Kyung-Wook Jee; Karen Vineberg; Marla Jablonowski; Benedick A Fraass; Charlie C Pan; Theodore S Lawrence; Randall K Ten Haken; Edgar Ben-Josef
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

4.  Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies.

Authors:  Arno J Mundt; Anthony E Lujan; Jacob Rotmensch; Steven E Waggoner; S Diane Yamada; Gini Fleming; John C Roeske
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-04-01       Impact factor: 7.038

5.  A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.

Authors:  L E Gaspar; K Winter; W I Kocha; L R Coia; A Herskovic; M Graham
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

6.  The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer.

Authors:  Kathy L Baglan; Robert C Frazier; Di Yan; Raywin R Huang; Alvaro A Martinez; John M Robertson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

7.  Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Authors:  Jonathan B Ashman; Michael J Zelefsky; Margie S Hunt; Steven A Leibel; Zvi Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

8.  Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Authors:  Edgar Ben-Josef; Anthony F Shields; Ulka Vaishampayan; Vainutis Vaitkevicius; Basil F El-Rayes; Patrick McDermott; Jay Burmeister; Todd Bossenberger; Philip A Philip
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

9.  Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.

Authors:  Michael T Milano; Steven J Chmura; Michael C Garofalo; Carla Rash; John C Roeske; Phillip P Connell; Oh-Hoon Kwon; Ashesh B Jani; Ruth Heimann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

10.  Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT.

Authors:  Frank Lohr; Barbara Dobler; Sabine Mai; Brigitte Hermann; Uta Tiefenbacher; Petra Wieland; Volker Steil; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2003-08       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.